Optometry News

In this Healio Video Perspective from the ASRS annual meeting, Dilraj Grewal, MD, FASRS, discusses eyes that developed macular neovascularization in the GATHER trials.

Use of a DPP-IV inhibitor, SGLT2 inhibitor or GLP-1 receptor agonist does not increase risk for diabetic macular edema among adults with type 2 diabetes and diabetic retinopathy, according to study data.

In this Healio Video Perspective, Cynthia Matossian, MD, FACS, and David Evans, PhD, MBA, share pearls on how to successfully navigate Google’s algorithm when marketing an ophthalmology practice.

In this Healio Video Perspective, Cynthia Matossian, MD, FACS, and David Evans, PhD, MBA, discuss how to revise or update a practice’s website without affecting its online ranking.

A form of dropless vitrectomy helped control intraocular inflammation and prevent infection after surgery for vitreous hemorrhage secondary to proliferative diabetic retinopathy, according to a study.

July is Dry Eye Awareness Month, but educating patients about symptoms and treatment is critical throughout the year, especially in light of recent data that show many American adults do not know relief is possible.

In this Healio Video Perspective from the ASRS meeting, Christina Y. Weng, MD, MBA, FASRS, of Baylor College of Medicine in Houston discusses 96-week safety and tolerability data for aflibercept 8 mg.

Low-dose 0.01% atropine eye drops safely slowed myopia progression in children with myopia and intermittent exotropia, with some compromise on accommodative amplitude.

Eluminex Biosciences has dosed the first patient in the phase 1b LOTUS trial, which will evaluate three dose levels of the trispecific fusion antibody EB-105 in patients with diabetic macular edema.

In a paper recently published in Retina, an expert panel of retina specialists provided guidance on suprachoroidal space injection.